Changes in Beneficial Ownership · 4
Aditxt, Inc.
Changes in Beneficial Ownership
Structured filing — 4
primary_doc.xml
Filing details
- Report period
- 2026-06-18
- Issuer
- Aditxt, Inc.
- Issuer CIK
- 0001726711
- Trading symbol
- ADTX
- No longer subject to Section 16
- Checked
Reporting owner 1
- Name
- HRT FINANCIAL LP
- Reporting owner CIK
- 0001475597
- Relationship
- 10% owner
- Address
- 3 WORLD TRADE CENTER, 175 GREENWICH STRE, 76TH FLOOR, NEW YORK, NY, 10007
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-06-18 | P · Form 4 | 7,340,178 | A | 0.013 | 2,406,438 | D |
| Common Stock | 2026-06-22 | S · Form 4 | 5,120,480 | D | 0.018 | 0 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Signature 1
- Signed
- Adam Nunes
- Date
- 2026-06-24
Company context
Aditxt, Inc. (NASDAQ: ADTX) is a public company focused on developing and commercializing health innovation platforms. Ignite Proteomics is currently a 100%-owned subsidiary of Aditxt. Through the proposed business combination, Aditxt expects to unlock value in Ignite at an implied equity value of approximately $150 million, while Ignite is expected to become an independent publicly traded company. Aditxt is expected to continue as a separate Nasdaq-listed public company, subject to continued compliance with Nasdaq listing requirements.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Termination of a Material Definitive AgreementOct 15, 2026
- 25-NSE - filed by Nasdaq Stock Market LLC regarding Aditxt, Inc.Oct 7, 2026
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingSep 23, 2026
- Other EventsAug 19, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesJul 17, 2026